ARCHIVES

Radiotherapy Plus Cetuximab May Control Head/Neck Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

Cancer Letter On Vacation

August 3, 1984

TGen’s Trent To Lead Van Andel Institute

February 13, 2009

Lombardi Center, Virgin Islands Collaborate On Patient Care

August 7, 1981

LDK378 Demonstrates 58 Percent Overall Response Rate in Phase I

April 25, 2014

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

April 26, 1996

Milken Calls For Renewed War On Cancer, $20 Billion A Year International Effort

November 24, 1995